Introduction
Quantification methods for gene expression have become important tools both in the understanding of the molecular events underlying human breast cancer and in the identification of diagnostic and therapeutic targets. Microarray expression profiling has provided an exciting new technology for attempting to identify gene-based classifiers that correlate with breast cancer diagnosis, disease prognosis, or prediction of response to treatment (1) (2) (3) (4) . A useful technique to confirm or use such classifiers is quantitative reverse transcriptionpolymerase chain reaction (RT-qPCR) assays of the selected genes (5) (6) (7) .
The development of molecular tests for clinical use has been limited by the lack of available clinical samples for validation of candidate biomarkers. Fresh frozen (FF) samples are difficult to collect for large scale studies, complicated to process, and expensive to store. Formalin-fixed, paraffin-embedded samples (FFPE) are stable at room temperature and easily storable, and-most importantthey constitute a widely available archive of clinical samples linked to precious clinical and follow-up information. Set against these advantages is the fact that RNA isolated from FFPE is considered a poor material for gene expression analysis, owing to its extensive degradation. While microarray-based studies are highly sensitive to RNA degradation, RT-qPCR appears to be more robust and tolerates partial degradation of RNA (8) . Although RNA degradation leads to a loss of amplifiable templates, optimized normalization strategies could effectively compensate for this bias (9) (10) (11) . Normalization is essential to control for experimental errors, such as the inherent variability of RNA, variability of extraction protocols that may co-purify inhibitors, and different reverse transcription and PCR efficiencies (12) .
In this study, we analyzed the correlation in gene expression measurements by RT-qPCR between breast cancer FF and FFPE tissues, and evaluated the performance of different normalization methods in compensating for the effect of RNA degradation. We also investigated the factors that could influence obtaining reliable results from FFPE samples.
Materials and methods
Tissue specimens Matching pairs of FF and FFPE biopsies of breast tumors from 30 patients (60 samples in total) were retrieved from the Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues Recent reports demonstrate the feasibility of quantifying gene expression by using RNA isolated from blocks of formalin-fixed, paraffin-embedded (FFPE) tumor tissue. The development of molecular tests for clinical use based on archival materials would be of great utility in the search for and validation of important genes or gene expression profiles. In this study, we compared the performance of different normalization strategies in the correlation of quantitative data between fresh frozen (FF) and FFPE samples and analyzed the parameters that characterize such correlation for each gene. Total RNA extracted from FFPE samples presented a shift in raw cycle threshold (Cq) values that can be explained by its extensive degradation. Proper normalization can compensate for the effects of RNA degradation in gene expression measurements. We show that correlation between normalized expression values is better for moderately to highly expressed genes whose expression varies significantly between samples. Nevertheless, some genes had no correlation. These genes should not be included in molecular tests for clinical use based on FFPE samples. Our results could serve as a guide when developing clinical diagnostic tests based on RT-qPCR analyses of FFPE tissues in the coming era of treatment decision-making based on gene expression profiling. 
Normalization factors
We applied two different published methods to identify genes that were expressed at essentially constant levels in our samples to use as endogenous controls. Vandesompele et al. (15) have written an application called geNorm that automatically calculates the gene stability measure for all genes in a given set of samples, and determines the optimal number of control genes needed for normalization. Andersen et al. (16) have described a novel evaluation strategy that considers whether the candidate genes show variation not only across the studied sample set, but also across sample subgroups. We used their bioinformatics tool, NormFinder, to find the best endogenous control gene and to determine the best combination of two genes, taking into consideration two subgroups, FF and FFPE samples, in order to find the best endogenous control genes in both materials. The program provides a stability value for each candidate gene and highlights the best gene with the lowest stability value for one group analysis (NormFinder), as well as the best combination of two genes for a two-gene normalization factor for two subgroups (NormFinder2).
The performance of the mean Cq per sample was also tested, which has been previously validated as a new method for miRNA RT-qPCR data normalization (17) . In addition, we developed a new model for selecting control genes based on housekeeping coefficient of variation (CV) and Pearson correlation coefficient of its expression with the mean gene expression per sample. We called this method NorMean:
where CV ij is the coefficient of variation for control gene i in material j, and r ij is the Pearson correlation coefficient of expression of gene i with the mean gene expression per sample in material j. This equation provides a value a i , which permits the ranking of control genes. Control genes with the lowest a i values are those with the most stable expression (low CV) and highest positive correlation with mean gene expression per sample. Those genes with r ≤ 0 should not be considered for NorMean analysis.
Using this ranking, we calculated different normalization factors by stepwise inclusion of control genes and geometric averaging of their expression levels. The optimal number of control genes for normalization was determined by comparing the percentage of significantly correlated genes between FF and FFPE materials using each normalization factor.
Given that there is a considerable shift in mean Cq values between FF and FFPE samples, we preferred to use CV over standard deviation, as previously done by others (18) (19) (20) (21) , because standard deviation is very sensitive to mean value, whereas CV expresses the standard deviation as a percentage of the sample mean.
Data presentation and calculations
Gene expression values were calculated based on the modified ∆∆Cq method described before (22) . Once the appropriate gene or set of genes to be used as controls were selected, we calculated a normalization factor (NF) using the geometric mean of the genes selected by each method. higher in RNA derived from FFPE material than in RNA prepared from FF samples (9, 10, 23) . The average expression levels of each tumor are visualized separately for FF and FFPE samples as box plots in Figure 1 . The raw Cq values are available in Supplementary  Tables S1 and S2 . Capillary electrophoresis analysis showed that RNA extracted from archival FFPE breast cancer specimens was essentially degraded (Supplementary Figure S1) , which is consistent with previous observations (9, 10) . This loss of intact amplicon template explains the five raw Cq shift observed in FFPE specimens with respect to the matched FF samples. The samples with a greater degree of RNA degradation showed higher median Cq values, confirming the inverse relation between average Cq and the quality of RNA.
Comparison of gene expression profiles between FF and FFPE tissues
We compared the RT-qPCR raw data of the 30 FF and FFPE sample pairs to measure the sample correlation coefficients. Correlation was assessed by calculating the Pearson's correlation coefficient of raw Cqs for 95 genes. A mean correlation coefficient of 0.81 ± 0.073 was found between the corresponding Cq values in the 30 tumors, ranging from 0.63 to 0.92. Figure 2 shows the mean raw Cq of each gene in both materials. In spite of the observed Cq shift, the correlation in Cq values between matched FF and FFPE tumor sample pairs was very high. In our opinion, however, these high correlation coefficients in raw pre-normalized data merely indicate that the relative level of expression of each gene is maintained in both materials; that is, genes with low Cqs (high level of expression) in FF samples have also low Cqs in FFPE samples, and vice versa.
Similarly, the gene correlation coefficients were determined across the sample series in FF and in FFPE. This gives rise to a much more relevant question, as it allows the assessment of whether the expression profile of a given gene is conserved in both materials. In this case, the correlations were lower, with a mean correlation coefficient of 0.33 ± 0.189, ranging from 0.005 to 0.81.
These results indicate that RNA degradation affects correlation in gene expression patterns between FF and FFPE materials, despite the fact that relative levels of expression are conserved for each gene. This could be due to the extensive degradation of RNA obtained from FFPE. Several studies have described that the observed changes in Cq values induced by RNA fragmentation can be partially compensated by appropriate normalization (9, 10, 23) .
Identification of endogenous control genes
We used two previously described methods of normalization, geNorm (15) and NormFinder (16) , to select genes with more stable expression. Given that mean gene expression of each sample reflects the quality of the RNA isolated from that sample, we also tested the performance of mean Cq per sample as a normalization factor.
Finally, we have developed a new model for selecting control genes. We propose that the normalization factor should be able to control for the various levels of experimental variability in RT-qPCR, mainly the quantity of RNA and differences in enzymatic efficiencies, as well as for differences in the quality of the starting material. As we have seen, the mean expression of each sample reflects its RNA quality. Correspondingly, we generated a model that took into account the control gene coefficient of variation as a measure of expression stability, and the Pearson correlation coefficient with the mean gene expression per sample as a measure of correlation with global sample behavior (see "Materials and methods" section). The first part of the model should correct for the differences in RNA quantity and enzyme efficiencies, and the second part should correct for the differences in RNA quality. We called this model NorMean. The best endogenous control genes obtained by each of these four methods are shown in Table 1 .
Comparison of normalization methods
Given that different methods of selection of control genes provided diverse lists of such genes, we evaluated the correlation of expression data using distinct normalization factors ( Table 2 ). The highest correlations were observed between geNorm and NorMean, while NormFinder2 and NorMean showed the lowest correlations. It was striking to observe that the degree of correlation for each gene in the same material was very high, independent of the normalization method employed. Moreover, we would like to highlight the good performance of single gene-based normalization factors compared with mutigene normalization methods, although it has been described that multigene normalization methods outperform single gene-derived normalization methods (15, 16, 24) . These results suggest that effective normalization could be achieved by different strategies in one material.
Subsequently, we assessed the correlation of normalized gene expression data between FF and FFPE samples. When data were normalized using geNorm, correlation coefficients for each gene across the 30 matched samples ranged -0.098-0.951 (mean = 0.56). The respective values for NorMean ranged 0.074-0.936 (mean = 0.57). We then compared the performance of each normalization method by contrasting the percentage of genes that show a significant correlation coefficient between FF and FFPE ( Figure 3 ). Raw Cq data showed only 40% of significantly correlated genes between both materials. All normalization factors included in this study increased the percentage of genes significantly correlated. The best results were obtained with the normalization factor derived from NorMean, with >80% of genes Tables S1 and S2 ). We carried out the same analyses described in the previous paragraph. In this case, raw Cq data showed <30% of significantly correlated genes between both materials. Once more, all normalization factors improved the percentage of genes with significant positive correlation (Figure 3 ). Despite the fact that in this series of TLDAs, NormFinder2 was the normalization factor that provided the best results (88% of significantly correlated genes), NorMean showed a similar performance (84% of significantly correlated genes). Moreover, it presented the maximum stability among the different models tested: in both the 95-gene and the 63-gene series of TLDAs, over 80% of genes showed positive correlation between FF and FFPE materials.
NorMean provides a method to select control genes that resemble the mean expression value, which has been previously shown to outperform the current normalization strategies (17) . However, mean expression value normalization is only valid if a large number of genes are profiled, which occurs in initial screening experiments but almost never in subsequent studies on a limited number of genes.
Analysis of assay performance
Our results consistently show that the NorMean normalization procedure is suitable to efficiently compensate for the changes in expression levels resulting from RNA degradation. Some genes showed a positive correlation between FF and FFPE tissues even without normalization-it is very significant that this group of genes includes estrogen receptor (ESR1) and progesterone receptor (PGR)-but the great majority showed a statistically significant positive correlation coefficient between FF and FFPE materials only when appropriately normalized (ERBB2, AURKA, and CCNB1). Nevertheless, there also exist a number of genes whose expression profiles cannot be compared between FF and FFPE samples, because their normalized expression values lack correlation (FLT1, AKAP2, and FGF18). We investigated the factors that could explain the behavior of these poorly correlated genes.
It has been described that amplicon length is related to RT-qPCR performance in severely degraded RNA (9, 10) . It has been also reported that genes with the largest dynamic range in expression present the highest positive correlation between FF and FFPE (23) . Therefore, we carried out a discriminant analysis in order to define the parameters that could characterize the genes lacking correlation between normalized expression values in FF and FFPE samples. We evaluated the influence of amplicon length, CV, mean and median Cq, trimmed mean Cq, minimum Cq, range, interquartilic range, and standard deviation in each material independently. The discriminant analysis selected CV of the normalized expression values and minimum raw Cq as the most influential parameters on the correlation of gene expression between FF and FFPE. These results agree with previously published data. CV is a measure of the variability in expression of a gene and minimum Cq reflects the level of expression of that gene. Both parameters have been identified as the most decisive in the positive correlation of gene expression measurements between RT-qPCR and microarrays (19-21,23). However, these factors cannot determine a priori those genes showing good correlation. It was impossible to create a model, based on these factors, able to predict the behavior of a given gene. In summary, in this work we demonstrate that RT-qPCR using TLDAs can be applied to FFPE samples. This powerful technology allows the expression profiling of tens to hundreds of genes in hundreds of clinical samples. Although RNA derived from FFPE archival samples is extensively degraded, which inevitably affects the correlation with RT-qPCR measurements from FF samples, proper normalization is able to compensate, to some extent, the effects of RNA degradation. Nevertheless, careful selection of candidate biomarkers should be made: those genes that show no correlation between FF and FFPE should not be included in molecular tests for clinical use based in FFPE samples. Moreover, in order to guarantee reliable results in gene expression measurements, we strongly encourage performing preliminary studies, with the aim of discarding non correlated genes. These results could serve as a guide when developing clinical diagnostic tests based on RT-qPCR analyses of FFPE tissues in the coming era of treatment decision-making based on gene expression profiling. 
